Weekly paclitaxel-cisplatin administration with G-CSF support in advanced breast cancer. A phase II study

By Frasci Giuseppe   Comella Pasquale   D'Aiuto Giuseppe   Budillon Alfredo   Barbarulo Deborah   Thomas Renato   Capasso Immacolata   Casaretti Rossana   Daponte Antonio   Caponigro Francesco   Gravina Adriano   Maiorino Luigi   Caratení Giacomo   Gentile Alfonso   Comella Giuseppe  

Breast Cancer Research and Treatment, Vol. 49, Iss. 1, 1998-05 ,pp. : 13-26

Springer Publishing Company

Access to resources Recommend Favorite

A Phase I/II Study of Dose-Intense Paclitaxel with Cisplatin and Cyclophosphamide as Initial Therapy of Poor-Prognosis Advanced-Stage Epithelial Ovarian Cancer

By Kohn E.C.   Sarosy G.A.   Davis P.   Christian M.   Link C.E.   Ognibene F.P.   Sindelar W.F.   Jacob J.   Steinberg S.M.   Premkumar A.   Reed E.  

Gynecologic Oncology, Vol. 62, Iss. 2, 1996-08 ,pp. : 181-191

Academic Press

Access to resources Recommend Favorite

Cisplatin–epirubicin–paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology group (SICOG) phase II study

By Frasci G.  

Breast Cancer Research and Treatment, Vol. 62, Iss. 2, 2000-07 ,pp. : 87-97

Springer Publishing Company

Access to resources Recommend Favorite

Cost-effectiveness analysis of paclitaxel and cisplatin versus cyclophosphamide and cisplatin as first-line therapy in advanced ovarian cancer. A European perspective

By Berger K.   Fischer T.   Szucs T.D.  

European Journal of Cancer, Vol. 34, Iss. 12, 1998-11 ,pp. : 1894-1901

Elsevier

Access to resources Recommend Favorite

Docetaxel and cyclophosphamide as adjuvant chemotherapy for early breast cancer: primary prophylaxis with G-CSF is required

By Lakhanpal Roopa   Stuart-Harris Robin   Chan Arlene   Kotasek Dusan   Beith Jane   Cuff Katharine   Bastick Patricia   Lee Clara  

Breast Cancer Management, Vol. 2, Iss. 5, 2013-09 ,pp. : 367-374

Future Medicine

Access to resources Recommend Favorite